Public Alert No. 033/2024 – Alert on the Recall of Radox Care + Moisturise Liquid Hand Wash due to presence of Butyphenyl Methylpropional (BMHCA) Content
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of the recall of Radox Care + Moisturise Liquid Hand Wash by the European Union (EU) in Brussels, Belgium. The product does not comply with the Cosmetic Products Regulation as it is said to contain Butyphenyl Methylpropional (BMHCA) which is […]
Public Alert No. 032/2024 – Singapore to Ban Formaldehyde in Interior Paints over health concerns by 2026
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public that Singapore’s National Environment Agency (NEA) is banning the sale of indoor paints containing formaldehyde from 1 January 2026. To ensure compliance, paint manufacturers and importers will be mandated to submit test reports demonstrating that the formaldehyde content in their […]
Press Briefing on WHO PQ of Swiss Pharma{Swipha}‘s Second Product Antimalarial: Sulfadoxine/Pyrimethanine Tablets {SP Combination}
PROTOCOL The National Agency for Food and Drug Administration and Control (NAFDAC) was set up by act of the parliament (Act Cap N1 LFN 2004 as amended) to regulate and control the manufacture, importation, exportation, distribution, advertisement, sale and use of Food, Drugs, Cosmetics, Medical Devices, Packaged Water, Chemicals and Detergents” (collectively known as regulated […]
Remarks and Talking Points of Prof. Mojisola Christianah Adeyeye Phd, Fas; at the NAFDAC Export Stakeholder Interactive Session on NAFDAC Export Regulations
Remarks by Prof. Adeyeye C M, Director General NAFDAC NAFDAC Export Stakeholder Interactive Session on NAFDAC Export Regulations NAFDAC PID Conference Centre, Yaba, Lagos 20th May, 2024. PROTOCOLI was quite curious to find out today what exactly the Cocoa Stakeholders are concerned with, especially in the draft Cocoa regulations we have posted for comments. First, let […]
Public Alert No. 031/2024 – Illegal Sale of Substandard and Falsified (SF) Colamar (Artemether/Lumefantrine 20/120mg) Oral Suspension
The National Agency for Food and Drugs Administration and Control (NAFDAC) informs the public of the illegal distribution and marketing of a substandard and falsified anti-malaria, Colamar (Artemether/Lumefantrine 20/120mg). The Substandard and falsified product is a pass-off of Lonart Suspension and has a fake NAFDAC Registration Number (NRN): B4-4065 which is a registration number of Malasyn Tablets […]
Public Alert No. 030/2024 – Alert on Confirmed Counterfeit of Avastin in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) informs the healthcare providers and the public of a report of Confirmed Counterfeit of Avastin in Nigeria. The Marketing Authorization Holder (MAH) Roche reported that an oncologist from a local hospital raised the suspicion for counterfeited material of Avastin Vials 400 mg/16 ml, batch […]
Public Alert No. 029/2024 – Alert on Confirmed Counterfeit of Tecentriq Injection in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) informs the healthcare providers and the public of a report of Confirmed Counterfeits of Tecentriq injection in Nigeria. The Marketing Authorization Holder (MAH) Roche reported that an oncologist from a local hospital raised the suspicion for counterfeited material of Tecentriq Vials 1200 mg/20 ml, […]
Public Alert No. 028/2024 – Alert on Confirmed Counterfeits of Perjeta in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) informs the healthcare providers and the public of a report of Confirmed Counterfeits of Perjeta in Nigeria. The Marketing Authorization Holder (MAH) Roche received a complaint from a pharmacist reporting two units of suspected counterfeit Roche products, Perjeta 420 mg/14mL. For the technical investigation, […]
Public Alert No. 027/2024 – Alert on Confirmed Counterfeit of Herceptin in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) informs the healthcare providers and the public of a report of Confirmed Counterfeit of Herceptin in Nigeria. The Marketing Authorization Holder (MAH) Roche received a complaint from a pharmacist reporting two units of suspected counterfeit Roche product, Herceptin 600 mg/5 ml. For the technical […]
Public Notice No. 026/2024 – Notice to Uninstall and Reinstall Med Safety App Important Update for Med Safety App Users
Dear Valued Users, We hope this message finds you well. We are excited to announce that several important updates have been rolled out for the Med Safety App, enhancing its functionality and user experience. These updates include vital bug fixes and improvements that have been developed and deployed over the years. To ensure you receive […]
